Our team
Expertise in ocular biology, gene delivery and clinical medicine, with experience taking an sCD59 gene-therapy approach into clinical development.
Founder and CEO
Professor at Tufts University School of Medicine, with expertise in ocular genetics, retinal gene delivery and complement biology. Previously Scientific Founder and Chief Scientific Officer of Hemera Biosciences and inventor of the sCD59 gene-therapy approach.
Senior Scientist
Expertise in retinal disease models and recombinant AAV. His background spans Tufts University and industry work in CNS and ocular gene therapy at PTC Therapeutics.
Clinical and Scientific Advisor
Physician-scientist with training in neuroscience and medicine at the University at Buffalo, and published work on molecular approaches to inherited retinal degeneration.
Scientific foundation
Ocular genetics / Vector engineering / Complement biology / Clinical perspective
Strategic partnerships
Technology collaborations, strategic partnerships and investment discussions.